CRISPR/Cas9-based targeting of fluorescent reporters to human iPSCs to isolate atrial and ventricular-specific cardiomyocytes
Orlando Chirikian(Cardiovascular Institute of the South), Sean M. Wu(Palo Alto University), Soah Lee(Sungkyunkwan University), William R. Goodyer(Cardiovascular Institute of the South), Francisco X. Galdos(Cardiovascular Institute of the South), Aimee Beck(Cardiovascular Institute of the South), Wesley L. McKeithan(MACOM (United States)), Mark Mercola(Institute for Medical Research), Joseph C. Wu(Cardiovascular Institute of the South), Beth L. Pruitt(University of California, Santa Barbara), Jan W. Buikema(Utrecht University), Sharon L. Paige(Cytokinetics (United States)), Elda Dzilic(Cardiovascular Institute of the South), Vahid Serpooshan(Georgia Institute of Technology), Guang Li(Cardiovascular Institute of the South), Haodi Wu(King University), Markus Merk(University of California, Santa Barbara), Alexandre J. S. Ribeiro(Carnegie Mellon University)
Cited by 33
Related Papers
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives
|Nature Reviews Cardiology|2020|1.5k
Wnt antagonism initiates cardiogenesis in <i>Xenopus laevis</i>
|Genes & Development|2001|482
Lentiviral Vectors and Protocols for Creation of Stable hESC Lines for Fluorescent Tracking and Drug Resistance Selection of Cardiomyocytes
|PLoS ONE|2009|232
Wnt Activation and Reduced Cell-Cell Contact Synergistically Induce Massive Expansion of Functional Human iPSC-Derived Cardiomyocytes
|Cell stem cell|2020|232
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2023|192